向糖基化以增强瘤免疫疗法
Qiang Zhu1, Xiaoming Chen2, Xiaotao Duan3
1Department of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Trends in pharmacological sciences
|August 15, 2025
概括
瘤微环境 (TME) 中改变的细胞表面糖 (糖类) 会削弱免疫反应. 操纵这些甘氨酸提供了一个有希望的策略,以提高癌症免疫治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 葡萄糖生物学 葡萄糖生物学
- 癌症生物学 癌症生物学
背景情况:
- 细胞表面的甘氨酸在生物过程中起着至关重要的作用.
- 在瘤微环境 (TME) 中异常的糖化促进免疫逃避.
- 改变的甘氨酸模式会产生"糖密码",阻碍抗癌免疫力,降低免疫疗法的有效性.
研究的目的:
- 审查异常糖化对瘤免疫力的影响.
- 探索操纵糖化酶的策略,以改善抗瘤免疫反应.
- 突出糖化在开发个性化癌症疗法的重要性.
主要方法:
- 审查当前关于糖化和瘤免疫力的文献.
- 分析异常葡萄糖酶化影响免疫监测的机制.
- 识别和分类的策略,以调节TME的糖基化.
主要成果:
- 在TME中异常的糖化显著影响免疫细胞的功能和相互作用.
- 甘氨基化操纵策略显示了增强抗瘤免疫力的潜力.
- 针对甘氨酸-受体相互作用,细胞表面甘氨酸和细胞外矩阵重塑是关键的方法.
结论:
- 糖化是瘤免疫反应的关键调节者.
- 针对性地操纵糖基化,为癌症治疗提供了一个可行的治疗途径.
- 了解和利用"糖密码"对于推进个性化癌症免疫疗法至关重要.
更多相关视频
13:36Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
3.6K
10:59Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
1.3K
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Protein Glycosylation
7.3K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Oligosaccharide Assembly
3.0K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.0K
